• Noting how an antibody to a ingested material can be linked to another

    From Treon Verdery@21:1/5 to All on Wed Mar 1 10:18:13 2023
    like dopamine receptors, So, when the antibody-drug gloms to the ingested material, it releases the codrug, causing a beneficial effect, is it possible that people with mental illness, like depression produce more of some chemical at their circulatory
    system? If they do, then antibodies with glomming released codrugs to that chemical could glom in proportion to the amount of that circulating chemical, which would cause another drug molecule to be released with each glomming, the released chemical
    would then address the mental illness, so if a depressed person makes more of some chemical at thier circulatory system, that chemical gets glommed, releasing drug molecules which causes the person to cheer up,

    I looked online and there is no one chemical that is a biomarker for depression, but there are numerous possibilities, some actual possible chemicals are:
    “Only cortisol was identified as potential predictor for MDD, but results are influenced by the disease state.”

    cortisol elevates with stress, so elevated cortisol persons might benefit from a beetter than well drug, perhaps relaxing, or optimism inducing, that also treats depression in those with depression

    “The study by a group of researchers from around the U.S. and in Sweden finds that a specific, naturally-occurring chemical, called acetyl-L-carnitine, or LAC, is lower in the blood of people suffering from depression.

    Researchers found a strong correlation between CRP levels and which drug regimen improved their symptoms:

    • For patients whose CRP levels were less than 1 milligram per liter, escitalopram alone was more effective: 57 percent remission rate compared to less than 30 percent on the other drug.
    • For patients with higher CRP levels, escitalopram plus bupropion was more likely to work: 51 percent remission rate compared to 33 percent on escitalopram alone.

    This review provides a summary on the potential of peripheral biomarkers in major depression with a specific emphasis on those related to inflammatory/immune and oxidative stress/antioxidant defences. The complexities associated with biomarker assessment
    are reviewed specifically around their collection, analysis and interpretation. Focus is placed on the potential of peripheral biomarkers to aid diagnosis, predict treatment response, enhance treatment-matching, and prevent the onset or relapse of major
    depression.

    Previous article in issue
    Next article in issue
    Abbreviations
    8-OHdG
    8-hydroxy-2-deoxyguanosine
    8-oxoGuo
    8-oxo-7,8-dihydroguanosine
    BDNF
    brain-derived neurotropic factor
    BMI
    body mass index
    COX
    cyclooxygenase
    CRP
    C-reactive protein
    DSM
    Diagnostic and Statistical Manual of Mental Disorders
    ECT
    electroconvulsive therapy
    ESR
    erythrocytes sedimentation rate
    F2-isoPM
    2,3-dinor-5,6-dihydro-15-F2t-isoprostane
    GPx
    glutathione peroxidase
    GTP-CH1
    GTP cyclohydrolase I
    hs-CRP
    high sensitivity CRP
    IDO
    indoleamine 2,3 dioxygenase
    IFN
    interferon
    IL
    interleukin
    IL-2R
    interleukin-2 receptor
    KYN
    kynurenine
    KYNA
    kynurenic acid
    MDA
    malondialdehyde
    RA
    rheumatoid arthritis
    RBC
    red blood cell
    RNA
    ribonucleoside
    SOD
    superoxide dismutase
    SSRI
    serotonin reuptake inhibitor
    TNF
    tumour necrosis factor
    TRP
    tryptophan
    TRYCATs
    tryptophan catabolites along the IDO pathway

    As compared with healthy controls, depressed patients were characterized by higher lipid/protein complex levels [low-density lipoprotein, very low-density lipoprotein, N-acetylglycoprotein and unsaturated lipid associated with lower individual amino acid
    levels (glycine, taurine, glutamine, alanine, valine, and leucine) and lower levels of other metabolites (glucose, myo-inositol, creatinine, creatine, acetate, lactate, and pyruvate)]. Taken together, NMR-based plasma metabonomics may represent a highly
    promising new biomarker research approach in MDD.

    reminded of phase locked loops, and there are optical phase locked loops, the input frequency has jitter, and subtracting the jitter from the jitter from the input frequency leaves a higher frequency component, although stochastic the jitter can then be
    converged around just one frequency of the jitter to generate a homogenous, higher frequency waveform higher than the input frequency; can this be used to generate a higher optical frequency than the input frequency, I read that at computers a crystal of
    like 200 mHz is used to generate a 2-4 gHz frequency the computer uses with the assistance of a phase locked loop


    --- SoupGate-Win32 v1.05
    * Origin: fsxNet Usenet Gateway (21:1/5)